Search
Polidocanol
go.drugbank.com/drugs/DB06811ApprovedInvestigationalPolidocanol is a sclerosing agent indicated to treat uncomplicated spider veins (varicose veins ≤1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremity. It is marketed under the ...
Mixtures: SOLCOSERYL ADHEZIV DIS PATI, 5 GBladder Cancers
go.drugbank.com/conditions/DBCOND0050427Synonyms: Malignant neoplasm of bladder, part unspecifiedProteinase-activated receptor 2
go.drugbank.com/bio_entities/BE0010726TargetHumansCan also be transactivated by cleaved F2R/PAR1. … Mediates phosphorylation of nuclear factor NF-kappa-B RELA subunit at 'Ser-536'; the function involves IKBKB and is predominantly independent of G proteins. Involved in cellular migration.
Synonyms: PAR2, PAR-2Upadacitinib
go.drugbank.com/drugs/DB15091ApprovedInvestigational[A189165] Despite a variety of therapeutic agents available for treatment, up to 40% of the patients do not respond to current therapies, including biological therapies. … [A189168] To reduce dose-related toxicity (as seen with some pan-JAK inhibitors) without significantly affecting efficacy, more selective JAK1 inhibitors, upadacitinib and [filgotinib], were developed.
Bisoctrizole
go.drugbank.com/drugs/DB11262ApprovedBisoctrizole is not approved by the FDA, but is approved in the EU and other parts of the world as a UV-filter in sunscreens, day care products and skin lightening products at a maximum concentration of
Equus caballus hair
go.drugbank.com/drugs/DB10880ApprovedHorse hair is used in allergenic testing.
Mixtures: Treatment Set TS128870, Treatment Set TS344005Azemiglitazone
go.drugbank.com/drugs/DB16028Investigationalof Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients). … Azemiglitazone is under investigation in clinical trial NCT01280695 (A Randomized, Double-blind, Comparator- and Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability and Efficacy
CRx-401
go.drugbank.com/drugs/DB05775ExperimentalIt consists of a low dose of the analgesic diflunisal in conjunction with a modified-release therapeutic dose of bezafibrate, an anti-cholesterol agent. … In third-party clinical studies, the dose of bezafibrate contained in CRx-401 has been observed to have a positive impact on cellular pathways that influence glycemic and lipid profiles, and this dose
Lolium perenne pollen
go.drugbank.com/drugs/DB10389ApprovedLolium perenne pollen is the pollen of the Lolium perenne plant. Lolium perenne pollen is mainly used in allergenic testing.
Mixtures: Treatment Set TS333938, Treatment Set TS128872